To describe a case of unilateral acute idiopathic maculopathy (UAIM) response to intravitreal therapy with aflibercept (Eylea).
Retrospective case report.
A 36-year-old woman with sudden visual impairment and central scotoma was found to have a UAIM in her left eye. Three weeks after continuous worsening of her visual acuity and central scotoma, the patient was treated with intravitreal injections of aflibercept. The visual acuity increased and the macula lesion regressed, causing macula scarring after 2 injections.
Intravitreal injections of aflibercept could be a therapy option in patients with UAIM without signs of spontaneous resolution of the clinical manifestations and visual improvement.
Post author correction
Article Type: CASE REPORT
Article Subject: Retina MED
AuthorsGeorgios Mylonas, Franz Prager, Barbara Wetzel, Panagiotis Malamos, Gabor Deak, Michael Amon
- • Accepted on 15/10/2017
- • Available online on 28/10/2017
This article is available as full text PDF.
- Mylonas, Georgios [PubMed] [Google Scholar] 1, 2, * Corresponding Author (email@example.com)
- Prager, Franz [PubMed] [Google Scholar] 1, 2
- Wetzel, Barbara [PubMed] [Google Scholar] 1, 2
- Malamos, Panagiotis [PubMed] [Google Scholar] 3
- Deak, Gabor [PubMed] [Google Scholar] 4
- Amon, Michael [PubMed] [Google Scholar] 1, 2
Department of Ophthalmology, Academic Teaching Hospital of St. John of God, Vienna - Austria
Sigmund Freud University, Medical School, Vienna - Austria
1st Department of Ophthalmology, “G. Gennimatas” General Hospital of Athens, University of Athens, Psychiko, Athens - Greece
Department of Ophthalmology, Medical University of Vienna, Vienna - Austria